GeneFerm Biotechnology Co Ltd (1796) — Working Capital to Net Assets Ratio
GeneFerm Biotechnology Co Ltd (1796) has a Working Capital to Net Assets ratio of 51.3% as of June 2025. Working capital of NT$407.33 Million (current assets of NT$541.91 Million minus current liabilities of NT$134.58 Million) is measured against net assets of NT$794.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can GeneFerm Biotechnology Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GeneFerm Biotechnology Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how GeneFerm Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 51.3%, reflecting working capital of NT$407.33 Million against net assets of NT$794.03 Million TWD. For the complete balance sheet picture, see GeneFerm Biotechnology Co Ltd asset portfolio.
Annual Working Capital to Net Assets for GeneFerm Biotechnology Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for GeneFerm Biotechnology Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 1796 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 35.2% | NT$277.71 Million | NT$788.18 Million | NT$411.97 Million | NT$134.26 Million | ▲ +12.0 pp |
| 2023 | 23.2% | NT$207.27 Million | NT$892.84 Million | NT$397.13 Million | NT$189.86 Million | ▲ +7.0 pp |
| 2022 | 16.2% | NT$134.32 Million | NT$830.77 Million | NT$373.54 Million | NT$239.22 Million | ▼ -28.5 pp |
| 2021 | 44.7% | NT$334.00 Million | NT$747.66 Million | NT$765.18 Million | NT$431.18 Million | ▼ -61.3 pp |
| 2020 | 105.9% | NT$419.73 Million | NT$396.19 Million | NT$535.58 Million | NT$115.85 Million | ▲ +108.5 pp |
| 2019 | -2.5% | NT$-24.31 Million | NT$954.50 Million | NT$21.69 Million | NT$46.00 Million | ▼ -49.4 pp |
| 2018 | 46.8% | NT$195.13 Million | NT$416.51 Million | NT$283.31 Million | NT$88.17 Million | ▲ +18.1 pp |
| 2017 | 28.8% | NT$90.62 Million | NT$314.95 Million | NT$236.26 Million | NT$145.63 Million | — |